Labs plead with Pence for help with coronavirus test supplies

By LabPulse.com staff writers

July 10, 2020 -- Organizations representing laboratory professionals have asked Vice President Mike Pence to address persistent supply problems that are hampering molecular and serology testing for the novel coronavirus.

Among other things, in a July 8 letter to Pence, the organizations asked for more transparency from the White House Coronavirus Task Force in providing information about who is in charge of supply chain issues in each state, and assurance that testing supplies and personal protective equipment (PPE) are being distributed appropriately.

"It is our understanding that the federal government is working with specific individuals in each state to direct the distribution of federally-allocated laboratory testing supplies and PPE," the letter stated. "However, many of our members report they are unable to identify or initiate contact with these individuals."

Pence, who has been front and center at recent pandemic response press briefings, and other task force officials, have repeatedly said that they will ensure labs get the supplies they need to meet testing targets. However, a number of surveys have shown a persistent lack of supplies needed to fulfill capacity, such as swabs and reagents.

"At times, our members have even received faulty or unusable equipment, including swabs from the Strategic National Stockpile, which has further impeded our work to combat this pandemic," they told Pence.

The following organizations signed the letter:

  • American Association of Bioanalysts
  • American Association for Clinical Chemistry
  • American Medical Technologists
  • American Society for Microbiology
  • Association of Public Health Laboratories
  • Association for Molecular Pathology
  • College of American Pathologists
  • National Independent Laboratory Association
Coronavirus testing in schools is a work in progress
Officials on the White House Coronavirus Task Force are urging the reopening of schools and suggested that antigen testing and saliva specimen collection...
World market outlook: COVID-19 testing evolves rapidly, lessons sink in
Worldwide, COVID-19 testing volume was on target to grow 25%-30% from May to June, reports Kalorama Information analyst Justin Saeks.
The case for a national COVID-19 testing strategy: A Q&A with Dr. Gary Procop
Dr. Gary Procop, chair of the American Society for Clinical Pathology's commission on science, technology, and policy, makes the case for a national testing...
AMP survey shows labs' struggles with COVID-19 supply shortages
A survey conducted by the Association for Molecular Pathology (AMP) illustrates the challenges clinical labs have faced in securing supplies for COVID-19...
Trump signs off on $2.2T economic relief CARES bill
President Donald Trump on March 27 signed off on a $2.2 trillion economic relief package, complete with provisions that laboratory associations had been...

Copyright © 2020 LabPulse.com

Last Updated ls 7/9/2020 4:40:42 PM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current